1 citations
,
April 2022 in “JAAD case reports” In this case report, researchers observed that a 47-year-old woman developed pityriasis amiantacea after using topical minoxidil, suggesting a potential new etiology for this scalp condition.
1 citations
,
March 2022 in “JAAD case reports” This review discusses traction alopecia, its causes, and common treatments, noting a lack of data on effective treatment options; the authors emphasize altering hair care practices to potentially reverse early-stage alopecia.
1 citations
,
January 2019 in “Acta dermato-venereologica” The woman's skin and hair symptoms were confirmed as frontal fibrosing alopecia, and while facial papules are common in such cases, there's no effective local treatment, but systemic treatments can help.
This source reports that modern hair transplant techniques, including follicular unit grafting, can create natural-looking results and are increasingly used beyond male pattern baldness to treat areas like eyebrows and scars, while even some controversial indications are being explored.
1 citations
,
January 2018 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)” This study found that a herbal shampoo and solution were more effective than placebo in reducing hair loss and improving hair growth in participants with androgenetic alopecia and telogen effluvium.
1 citations
,
September 2016 in “PubMed” This study found that adding topical finasteride 0.5% to diode laser therapy significantly reduced unwanted facial hair in women with idiopathic hirsutism compared to laser treatment with a placebo.
1 citations
,
October 2015 in “The Pharma Innovation Journal” This study found that the optimal method to introduce Saw Palmetto extract into emulsion bases for androgenic alopecia treatment involves mixing it with 48% ethanol at the end of the formulation process.
1 citations
,
January 2001 in “Cosmetics and toiletries” This study found that purified apple juice containing procyanidin B-2 promoted hair growth in both mouse models and human clinical trials for male pattern baldness.
1 citations
,
January 2000 in “PubMed” The treatment slightly increased hair growth and was safe for most women.
In a harbor seal from the Yellow Sea of Korea, this study found that alopecia-related lesions disappeared completely after treatment with internal and external ketoconazole, povidone iodine, cephalexin, and multivitamins over 8 months.
1 citations
,
February 2025 in “International Journal For Multidisciplinary Research” This study developed and validated a simple, accurate, and sensitive HPTLC method for estimating minoxidil and aminexil in topical solutions, demonstrating effective separation and linear measurement of these compounds with %RSD under 2% and high regression coefficients.
1 citations
,
December 2019 in “Formuly farmacii” This article reviews the complex etiology of alopecia and emphasizes the need for detailed pathogenesis studies in animal models to develop effective personalized treatments, without presenting new experimental data.
January 2026 in “Pharmaceutics” This review highlighted recent advances in nanocarrier-based topical delivery systems for skincare, emphasizing their potential to enhance ingredient stability, penetration, and targeted release while addressing specific pathophysiological skin concerns.
August 2025 in “SSP Modern Pharmacy and Medicine” This analytical review of alopecia treatments in the US found that drugs like minoxidil and finasteride are most affordable and effective, while newer JAK inhibitors show significant clinical results but are cost-prohibitive; the study stresses individualizing treatment based on financial capability and alopecia type.
May 2025 in “Plastic & Reconstructive Surgery Global Open” In this proof-of-concept study, researchers found that hair grafts preserved in preconditioned autologous platelet-rich plasma with photothermal biostimulation and phosphate-buffered saline remained viable for eight hours before transplantation, outperforming saline solution and Ringer's lactate by two hours.
December 2024 in “Skin Appendage Disorders” Researchers reviewed 13 clinical trials on non-prescription monotherapies like procyanidin and cetirizine for androgenetic alopecia, finding potential improvements in hair density and diameter, but emphasized the need for more robust trials to confirm efficacy and safety.
August 2024 in “Clinical and Medical Engineering Live” This abstract highlights that alopecia treatment requires moving beyond outdated methods to a sophisticated approach that considers the complex interplay between genetic susceptibility and immune response in different types of hair loss. Results are not reported.
May 2024 in “British Journal of Community Nursing” In this case series, researchers reviewed 38 case studies involving Prontosan® products for chronic lower limb ulcers and found that the treatments significantly improved wound healing and various quality of life outcomes, such as reduced malodour and pain, better mobility, and enhanced social life.
Quickly fix tissue in formalin after excision to preserve it.
February 2024 in “Trends in Sciences” This study examined the stability of two 5α-reductase inhibitors in Tectona grandis extracts, finding that they are more stable in acidic environments and degrade rapidly under heat and light unless protected, suggesting the need for careful storage when developing anti-hair loss medications.
This review discusses the criteria for evaluating treatments for androgenetic alopecia and emphasizes the importance of shared decision-making, noting no treatment currently meets all desired criteria of efficacy, safety, affordability, and ease of use.
July 2023 in “Annals of King Edward Medical University” This randomized clinical trial compared bimatoprost 0.03% solution and mometasone furoate 0.1% cream for treating alopecia areata in 60 patients, finding that mometasone furoate led to better hair regrowth, while both treatments showed significant effectiveness.
June 2023 in “JAAD case reports” This review discusses the evolution of the term “hot comb alopecia” to central cicatricial centrifugal alopecia (CCCA) and highlights the ongoing debate over hairstyling practices' role in its pathology, without offering new clinical results.
January 2023 in “Surgical & Cosmetic Dermatology” This study examined the effectiveness of using intradermotherapy, with or without microneedling and topical solutions, in reducing hair loss among men with androgenetic alopecia, though results are not reported in the abstract.
January 2022 in “International Journal of Research Publications” In this case report, an 8-year-old child with tinea capitis caused by Microsporum canis showed significant clinical and mycological improvement after a four-week course of oral griseofulvin, highlighting the importance of comprehensive diagnostic examinations to confirm the diagnosis and determine the best treatment.
September 2021 in “Kazanskij medicinskij žurnal” This article discusses the novel approach of introducing dissolved keratin into the body to enhance hair growth and reports no clinical results; further studies are needed to evaluate its efficacy.
January 2021 in “Research journal for veterinary practitioners” This study evaluated a commercial topical solution with essential fatty acids for its potential effectiveness in treating skin disorders in rabbits.
January 2021 in “대한피부과학회지” In this randomized controlled trial, the topical application of a PGA solution significantly increased hair density in patients with androgenetic alopecia compared to placebo, with no adverse reactions reported over 24 weeks, suggesting its potential as a safe and effective treatment option.
January 2020 in “Veterinary world/Veterinary World” This study found that a topical solution of essential oils, plant-extracted polyunsaturated fatty acids, and Vitamin E improved hair shine, reduced flaking and hair loss, and enhanced skin hydration in rabbits with skin issues.
June 2019 in “The Professional Medical Journal” In this prospective study, the addition of the steroid triamcinolone to the tumescent solution was significantly more effective in preventing post-operative edema in hair transplant patients than a postoperative oral steroid course, showing a 93.3% success rate compared to 57.8% in the oral steroid group.